Age distribution of latent herpes simplex virus 1 and varicella-zoster virus genome in human nervous tissue
about
Ocular herpes simplex virus: how are latency, reactivation, recurrent disease and therapy interrelated?Human herpesvirus-6 entry into the central nervous system through the olfactory pathwayTowards an understanding of the herpes simplex virus type 1 latency-reactivation cycleHerpes encephalitis is a disease of middle aged and elderly people: polymerase chain reaction for detection of herpes simplex virus in the CSF of 516 patients with encephalitis. The Study GroupNeurotropic viruses and Alzheimer's disease: a search for varicella zoster virus DNA by the polymerase chain reaction.Attenuated, replication-competent herpes simplex virus type 1 mutant G207: safety evaluation in miceAnalysis of individual human trigeminal ganglia for latent herpes simplex virus type 1 and varicella-zoster virus nucleic acids using real-time PCR.Herpes simplex virus-1 infects the olfactory bulb shortly following ocular infection and exhibits a long-term inflammatory profile in the form of effector and HSV-1-specific T cells.Corneal sensation and subbasal nerve alterations in patients with herpes simplex keratitis: an in vivo confocal microscopy study.Polymerase chain reaction as a diagnostic adjunct in herpesvirus infections of the nervous system.Herpes simplex virus type 1 and bovine herpesvirus 1 latency.Varicella zoster virus latency.Chronic progressive deficits in neuron size, density and number in the trigeminal ganglia of mice latently infected with herpes simplex virus.Review: The neurobiology of varicella zoster virus infection.The Current State of Vaccine Development for Ocular HSV-1 InfectionExposure to herpes simplex virus type 1 and cognitive impairments in individuals with schizophrenia.Can infections cause Alzheimer's disease?Intracerebral propagation of Alzheimer's disease: strengthening evidence of a herpes simplex virus etiologyThe high prevalence of herpes simplex virus type 1 DNA in human trigeminal ganglia is not a function of age or gender.Prophylactic vaccine strategies and the potential of therapeutic vaccines against herpes simplex virusCD8 T cells and latent herpes simplex virus type 1: keeping the peace in sensory ganglia.Ocular HSV-1 latency, reactivation and recurrent disease.Infectious agents and neurodegeneration.Control of HSV-1 latency in human trigeminal ganglia--current overview.The olfactory nerve: a shortcut for influenza and other viral diseases into the central nervous system.Amplification of herpes simplex virus type 1 DNA in human geniculate ganglia from formalin-fixed, nonembedded temporal bones.Thyroid hormone-dependent epigenetic suppression of herpes simplex virus-1 gene expression and viral replication in differentiated neuroendocrine cells.Presence of herpesvirus DNA in cerebrospinal fluid of patients with tick-borne encephalitis and enteroviral meningoencephalitis.Gene transfer by viral vectors for gene therapy.The pUL37 tegument protein guides alpha-herpesvirus retrograde axonal transport to promote neuroinvasion.Bilateral tear film alterations in patients with unilateral quiescent herpes simplex keratitis.Association of HSV reactivation and pro-inflammatory cytokine levels with the severity of stomatitis after BEAM chemotherapy and autologous SCT.
P2860
Q27021069-B34F93FF-D585-4588-9F4A-1913F85B5864Q28245161-42370428-AA56-4734-9EF9-F5B50C048CC1Q33654414-150D0B2D-0B21-499E-999E-9D4ECDA8BEDCQ33734938-B0A735C0-BE74-460D-8B30-9A552080B6B4Q33735839-D1CFAAE8-157D-4DE7-A8FF-2C2DAFA73728Q33802747-B6892332-0C88-4284-AC35-945EEED446E3Q33812187-E4481DD8-2245-4B72-939E-FF836A2F4914Q33827496-1C65747F-3C73-4761-927A-F49C9458AE7CQ34172867-C6B3CBAF-34D4-4FDF-802F-0892D3AEA30CQ34369547-899AF992-1B69-4472-BB68-B226B436731DQ35044114-DE3127CA-9C60-42C5-A7BE-A7379899D082Q35054349-6E0D8F94-7DE8-4BC9-9F5C-F4BFAC09B05EQ35074781-C5C8D617-09C6-4ABB-B7AC-F703D947127EQ35223289-7345FBE6-AE10-45E8-9844-0A6D2433FA13Q35606611-E739EF1D-9317-4BD7-8D82-7DD0EED714D2Q36386375-23FAE938-93C5-41C3-8D0A-D2718D3FD829Q36449877-68EBE2A5-2783-4011-98F9-6BE395B27847Q36628425-4B0316A6-20F8-4111-B742-366848A9A2E4Q36845587-DBC0E91D-8A74-44C3-BFA2-361F8D250D38Q36879345-2B56A1D4-003B-4932-AE65-3B3FFA23670AQ36922242-2335C7FA-3B60-443A-96EF-78DF77BA4561Q37201603-4563F3AD-3E14-4D16-9958-BDD9E1AA03C8Q37848266-257BA375-D415-459D-A3E1-4B5F5BD06F2EQ37964558-FD5EF1B4-010B-4B6D-A488-8CA15703813EQ38258061-791D4EC3-9678-4CFB-9BE0-1CBCDADE96F8Q38463729-A4020819-7146-4A17-8217-05C20CEBBE54Q38961062-EBF7F3BC-A409-4B84-891B-92479762B91BQ41430836-EF0DB401-1B1B-49FF-8C05-9AD5D1C54487Q45053353-0942314F-816E-4DFC-9F1F-B0373FA3CE1AQ47319444-376E5E82-3C42-4035-81C5-C5E29B556A25Q47965017-14B3E458-4419-4F11-8780-AF4FDE4D924BQ51680741-9DA30D90-DA96-4973-A963-EB046B7D24FE
P2860
Age distribution of latent herpes simplex virus 1 and varicella-zoster virus genome in human nervous tissue
description
1993 nî lūn-bûn
@nan
1993 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1993 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1993年の論文
@ja
1993年論文
@yue
1993年論文
@zh-hant
1993年論文
@zh-hk
1993年論文
@zh-mo
1993年論文
@zh-tw
1993年论文
@wuu
name
Age distribution of latent her ...... genome in human nervous tissue
@ast
Age distribution of latent her ...... genome in human nervous tissue
@en
Age distribution of latent her ...... genome in human nervous tissue
@nl
type
label
Age distribution of latent her ...... genome in human nervous tissue
@ast
Age distribution of latent her ...... genome in human nervous tissue
@en
Age distribution of latent her ...... genome in human nervous tissue
@nl
prefLabel
Age distribution of latent her ...... genome in human nervous tissue
@ast
Age distribution of latent her ...... genome in human nervous tissue
@en
Age distribution of latent her ...... genome in human nervous tissue
@nl
P2093
P1476
Age distribution of latent her ...... genome in human nervous tissue
@en
P2093
C W Zimmermann
P356
10.1016/0022-510X(93)90082-A
P407
P577
1993-05-01T00:00:00Z